Andrew John Liu
My current focus is to bridge discoveries made at the bench and facilitate clinical trials to determine the utility of these discoveries in various neurodegenerative diseases. A specific interest of mine involves neurodegenerative disorders due to the accumulation of tau more commonly known as tauopathies.
I am currently involved in several projects. In collaboration with Dr. Cathrine Hoyo, we are investigating the relationship between epigenetics and the development of Alzheimer's disease. Additionally, I am trying to clinically characterize a neurogenetic disorder called Tuberous Sclerosis Complex (TSC). Prior studies have shown that TSC patients develops a Frontotemporal Dementia syndrome due to the accumulation of phosphorylated tau later in life. I am also interested in investigating the genetics of Dementia with Lewy Body.
Education and Training
- Clinical Behavioral Fellowship, Memory And Aging Center, University of California, San Francisco, 2017 - 2019
- Neurology Residency, Neurology, Yale University School of Medicine, 2014 - 2017
- Internal Medicine Internship, Wayne State University School of Medicine, 2013 - 2014
- Master of Science, Biomedical Science, Rosalind Franklin University of Medicine and Science, 2007 - 2008
- M.D., Chicago Medical School at Rosalind Franklin University of Medicine and Science, 2013